Status:
RECRUITING
Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Schwab Charitable Fund
Conditions:
Huntington Disease
Eligibility:
All Genders
Brief Summary
This observational study aims to identify novel biomarkers of disease onset and progression in Huntington's disease by integrating remote monitoring with fluid biomarkers. Using video-based computer v...
Eligibility Criteria
Inclusion
- Individuals with a positive test for the HD expansion mutation.
Exclusion
- Individuals with movement disorders with a negative test for the HD expansion mutation.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06941662
Start Date
June 1 2024
End Date
December 1 2035
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94304